Prosecution Insights
Last updated: October 25, 2026

Tropic Biosciences UK Limited

Technology area: Biotechnology & Pharmaceuticals

6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready

Analysis

Tropic Biosciences UK Limited currently has 6 pending office actions and 6 distinct examiners in the Biotechnology & Pharmaceuticals technology area. These actions are concentrated within 4 distinct art units. The busiest examiner, PAGE, BRENT T, is responsible for 1 pending office action. This distribution shows a significant overlap at the art unit level, with only 4 distinct art units for 6 pending actions.

With these 6 pending office actions, the company must navigate various individual examination styles. However, the fact that these cases are housed in only 4 distinct art units suggests that some examiners are working in the same administrative groups. This could lead to more consistent application of legal standards or shared prior art across the portfolio. Practitioners should look for commonalities within the 4 distinct art units while preparing for the unique preferences of the 6 distinct examiners.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (17%)
5
Medium (83%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (17%)
§103 only3 (50%)
Double-patenting + other2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAGE, BRENT T 1 82.4% +10.7%
DEVEAU ROSEN, JASON 1 80.0% +16.3%
CHATTERJEE, JAYANTA 1 44.0% +70.1%
YU, DAVID TUYANG 1 100.0% +0.0%
SULLIVAN, BRIAN JAMES 1 76.5% +14.9%
VYAS, KEYUR ANILKUMAR 1 50.0% +58.7%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18720593 MODIFIED AGROBACTERIA FOR EDITING PLANTS DEVEAU ROSEN, JASON 66d overdue
18281163 METHOD FOR SILENCING GENES YU, DAVID TUYANG —

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19210663 MODIFYING THE SPECIFICITY OF PLANT NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION PAGE, BRENT T —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18149627 COMPOSITIONS AND METHODS FOR INCREASING SHELF-LIFE OF BANANA SULLIVAN, BRIAN JAMES 89d overdue
18720593 MODIFIED AGROBACTERIA FOR EDITING PLANTS DEVEAU ROSEN, JASON 66d overdue
18575208 METHOD FOR EDITING BANANA GENES CHATTERJEE, JAYANTA 11d overdue
19210663 MODIFYING THE SPECIFICITY OF PLANT NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION PAGE, BRENT T —
16648779 MODIFYING THE SPECIFICITY OF NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION IN EUKARYOTIC CELLS VYAS, KEYUR ANILKUMAR —

Top Art Units

Art UnitApps
1663 2
1662 2
1635 1
1637 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19210663 MODIFYING THE SPECIFICITY OF PLANT NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION PAGE, BRENT T 1663 §101§102DP Non-Final OA — Pending May 16, 2025
18720593 MODIFIED AGROBACTERIA FOR EDITING PLANTS DEVEAU ROSEN, JASON 1662 §103 Final Rejection 66d overdue Pending Jun 14, 2024
18575208 METHOD FOR EDITING BANANA GENES CHATTERJEE, JAYANTA 1662 §103 Non-Final OA 11d overdue Pending Dec 28, 2023
18281163 METHOD FOR SILENCING GENES YU, DAVID TUYANG 1635 §103§112DP Non-Final OA — Pending Sep 08, 2023
18149627 COMPOSITIONS AND METHODS FOR INCREASING SHELF-LIFE OF BANANA SULLIVAN, BRIAN JAMES 1663 §103 Non-Final OA 89d overdue Pending Jan 03, 2023
16648779 MODIFYING THE SPECIFICITY OF NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION IN EUKARYOTIC CELLS VYAS, KEYUR ANILKUMAR 1637 §103DP Final Rejection — Pending Mar 19, 2020

Managing Tropic Biosciences UK Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Tropic Biosciences UK Limited have?

Tropic Biosciences UK Limited has 6 pending office actions as of October 2026, spread across 4 art units and 6 examiners.

Which USPTO examiner handles the most Tropic Biosciences UK Limited applications?

Brent T Page has the most, with 1 of Tropic Biosciences UK Limited's pending office actions.

What technology area are Tropic Biosciences UK Limited's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month